← Back to patent-cliff list
Atropine Sulfate Eye Drops(Zhaoke (Guangzhou) Ophthalmology Pharma)
Tier C — Watch / tradeAtropine Sulfate Eye Drops(Zhaoke (Guangzhou) Ophthalmology Pharma)
Nevakar Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：mAChRs
Indications (approved)：近视
Regional status
US
-
EU
-
China
Phase III
2022-03-15
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Atropine Sulfate Eye Drops(Zhaoke (Guangzhou) Ophthalmology Pharma)?
Approved indications include: 近视.
When does the Atropine Sulfate Eye Drops(Zhaoke (Guangzhou) Ophthalmology Pharma) patent expire?
No public expiry year is available for Atropine Sulfate Eye Drops(Zhaoke (Guangzhou) Ophthalmology Pharma) yet; this page updates once verified.
How do I get a quote for Atropine Sulfate Eye Drops(Zhaoke (Guangzhou) Ophthalmology Pharma) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-05